Translation, revision, and validation of the chinese version of the satisfaction with oral anti-diabetic agent scale (C-SOADAS) in patients with type 2 diabetes mellitus

Yi Ju Lin, Chin Yuan Wang, Elizabeth H. Chang, Ssu Wei Cheng, Yu Ko

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: The aim of this study was to translate, adapt, and validate the Satisfaction with Oral Anti-Diabetic Agent Scale (SOADAS) in type 2 diabetes mellitus (DM) patients taking oral antidiabetic drugs (OADs) in Taiwan. Patients and methods: The SOADAS was translated to Chinese and was modified based on reviews of two physicians, five diabetes educators, and two patient focus groups. A cross-sectional interviewer-administered survey was conducted in adult patients with type 2 DM who were taking OADs. The Chinese version of the SOADAS (C-SOADAS), the EuroQol 5 dimensions 3-level (EQ-5D-3L) questionnaire, and a demographic questionnaire were administered to participants. Instrument structure, internal consistency, convergent validity, and known-group validity were assessed. Results: A total of 260 DM patients were recruited. The mean score of an individual item ranged from 3.6 to 3.9, while the mean total score (out of 25 possible points) was 18.7 points. Overall, floor and ceiling effects were negligible. The Cronbach’s α value was 0.81. All the four predetermined hypotheses for known-group validity assessment were fulfilled. In convergent validity testing, the C-SOADAS total scores were found to be correlated with EuroQol-Visual Analog Scale (EQ-VAS) scores (r = 0.2; p < 0.01) but not with EuroQol 5 dimensions (EQ-5D) index scores (r = 0.02; p = 0.81). Conclusion: The 5-item C-SOADAS appears to be a psychometrically acceptable measure of OAD treatment satisfaction among type 2 DM patients in Taiwan. The tool may be incorporated into clinical practice to quickly assess treatment outcomes from patients’ perspectives.

Original languageEnglish
Pages (from-to)667-672
Number of pages6
JournalPatient Preference and Adherence
Volume12
DOIs
Publication statusPublished - May 1 2018

Fingerprint

Type 2 Diabetes Mellitus
chronic illness
Hypoglycemic Agents
drug
Taiwan
questionnaire
Group
Focus Groups
Visual Analog Scale
physician
Diabetes Mellitus
educator
Demography
Interviews
Physicians
interview
Values
Surveys and Questionnaires

Keywords

  • C-SOADAS
  • Diabetes mellitus
  • Oral antidiabetic agent
  • Reliability
  • Satisfaction
  • Taiwan
  • Validation

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Social Sciences (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Health Policy

Cite this

@article{fb91981348114b68990009966a8d9127,
title = "Translation, revision, and validation of the chinese version of the satisfaction with oral anti-diabetic agent scale (C-SOADAS) in patients with type 2 diabetes mellitus",
abstract = "Objective: The aim of this study was to translate, adapt, and validate the Satisfaction with Oral Anti-Diabetic Agent Scale (SOADAS) in type 2 diabetes mellitus (DM) patients taking oral antidiabetic drugs (OADs) in Taiwan. Patients and methods: The SOADAS was translated to Chinese and was modified based on reviews of two physicians, five diabetes educators, and two patient focus groups. A cross-sectional interviewer-administered survey was conducted in adult patients with type 2 DM who were taking OADs. The Chinese version of the SOADAS (C-SOADAS), the EuroQol 5 dimensions 3-level (EQ-5D-3L) questionnaire, and a demographic questionnaire were administered to participants. Instrument structure, internal consistency, convergent validity, and known-group validity were assessed. Results: A total of 260 DM patients were recruited. The mean score of an individual item ranged from 3.6 to 3.9, while the mean total score (out of 25 possible points) was 18.7 points. Overall, floor and ceiling effects were negligible. The Cronbach’s α value was 0.81. All the four predetermined hypotheses for known-group validity assessment were fulfilled. In convergent validity testing, the C-SOADAS total scores were found to be correlated with EuroQol-Visual Analog Scale (EQ-VAS) scores (r = 0.2; p < 0.01) but not with EuroQol 5 dimensions (EQ-5D) index scores (r = 0.02; p = 0.81). Conclusion: The 5-item C-SOADAS appears to be a psychometrically acceptable measure of OAD treatment satisfaction among type 2 DM patients in Taiwan. The tool may be incorporated into clinical practice to quickly assess treatment outcomes from patients’ perspectives.",
keywords = "C-SOADAS, Diabetes mellitus, Oral antidiabetic agent, Reliability, Satisfaction, Taiwan, Validation, C-SOADAS, Diabetes mellitus, Oral antidiabetic agent, Reliability, Satisfaction, Taiwan, Validation",
author = "Lin, {Yi Ju} and Wang, {Chin Yuan} and Chang, {Elizabeth H.} and Cheng, {Ssu Wei} and Yu Ko",
year = "2018",
month = "5",
day = "1",
doi = "10.2147/PPA.S162268",
language = "English",
volume = "12",
pages = "667--672",
journal = "Patient Preference and Adherence",
issn = "1177-889X",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Translation, revision, and validation of the chinese version of the satisfaction with oral anti-diabetic agent scale (C-SOADAS) in patients with type 2 diabetes mellitus

AU - Lin, Yi Ju

AU - Wang, Chin Yuan

AU - Chang, Elizabeth H.

AU - Cheng, Ssu Wei

AU - Ko, Yu

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Objective: The aim of this study was to translate, adapt, and validate the Satisfaction with Oral Anti-Diabetic Agent Scale (SOADAS) in type 2 diabetes mellitus (DM) patients taking oral antidiabetic drugs (OADs) in Taiwan. Patients and methods: The SOADAS was translated to Chinese and was modified based on reviews of two physicians, five diabetes educators, and two patient focus groups. A cross-sectional interviewer-administered survey was conducted in adult patients with type 2 DM who were taking OADs. The Chinese version of the SOADAS (C-SOADAS), the EuroQol 5 dimensions 3-level (EQ-5D-3L) questionnaire, and a demographic questionnaire were administered to participants. Instrument structure, internal consistency, convergent validity, and known-group validity were assessed. Results: A total of 260 DM patients were recruited. The mean score of an individual item ranged from 3.6 to 3.9, while the mean total score (out of 25 possible points) was 18.7 points. Overall, floor and ceiling effects were negligible. The Cronbach’s α value was 0.81. All the four predetermined hypotheses for known-group validity assessment were fulfilled. In convergent validity testing, the C-SOADAS total scores were found to be correlated with EuroQol-Visual Analog Scale (EQ-VAS) scores (r = 0.2; p < 0.01) but not with EuroQol 5 dimensions (EQ-5D) index scores (r = 0.02; p = 0.81). Conclusion: The 5-item C-SOADAS appears to be a psychometrically acceptable measure of OAD treatment satisfaction among type 2 DM patients in Taiwan. The tool may be incorporated into clinical practice to quickly assess treatment outcomes from patients’ perspectives.

AB - Objective: The aim of this study was to translate, adapt, and validate the Satisfaction with Oral Anti-Diabetic Agent Scale (SOADAS) in type 2 diabetes mellitus (DM) patients taking oral antidiabetic drugs (OADs) in Taiwan. Patients and methods: The SOADAS was translated to Chinese and was modified based on reviews of two physicians, five diabetes educators, and two patient focus groups. A cross-sectional interviewer-administered survey was conducted in adult patients with type 2 DM who were taking OADs. The Chinese version of the SOADAS (C-SOADAS), the EuroQol 5 dimensions 3-level (EQ-5D-3L) questionnaire, and a demographic questionnaire were administered to participants. Instrument structure, internal consistency, convergent validity, and known-group validity were assessed. Results: A total of 260 DM patients were recruited. The mean score of an individual item ranged from 3.6 to 3.9, while the mean total score (out of 25 possible points) was 18.7 points. Overall, floor and ceiling effects were negligible. The Cronbach’s α value was 0.81. All the four predetermined hypotheses for known-group validity assessment were fulfilled. In convergent validity testing, the C-SOADAS total scores were found to be correlated with EuroQol-Visual Analog Scale (EQ-VAS) scores (r = 0.2; p < 0.01) but not with EuroQol 5 dimensions (EQ-5D) index scores (r = 0.02; p = 0.81). Conclusion: The 5-item C-SOADAS appears to be a psychometrically acceptable measure of OAD treatment satisfaction among type 2 DM patients in Taiwan. The tool may be incorporated into clinical practice to quickly assess treatment outcomes from patients’ perspectives.

KW - C-SOADAS

KW - Diabetes mellitus

KW - Oral antidiabetic agent

KW - Reliability

KW - Satisfaction

KW - Taiwan

KW - Validation

KW - C-SOADAS

KW - Diabetes mellitus

KW - Oral antidiabetic agent

KW - Reliability

KW - Satisfaction

KW - Taiwan

KW - Validation

UR - http://www.scopus.com/inward/record.url?scp=85047767849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047767849&partnerID=8YFLogxK

U2 - 10.2147/PPA.S162268

DO - 10.2147/PPA.S162268

M3 - Article

VL - 12

SP - 667

EP - 672

JO - Patient Preference and Adherence

JF - Patient Preference and Adherence

SN - 1177-889X

ER -